AXQ Capital
MAZE icon

AXQ Capital’s Maze Therapeutics MAZE Stock Holding History

AXQ Capital’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$326K Sell
11,991
-3,202
-21% -$88.8K 0.04% 566
2026
Q2 		$453K Buy
15,193
+8,098
+114% +$212K 0.05% 508
2026
Q1 		$212K Buy
+7,095
New +$313K 0.03% 727

Other funds holding MAZE

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return

AXQ Capital's MAZE Position: Q3 2026 in Review

AXQ Capital reduced its Maze Therapeutics (MAZE) stake by 21% in Q3 2026, selling an estimated $88.8K and leaving 11,991 shares worth $326K. The position accounts for 0.04% of the portfolio, ranked #566.

AXQ Capital first reported a position in MAZE in Q1 2026 and has held it in 3 quarters since. The position peaked at $453K in Q2 2026. 95 funds tracked by Wall St. Rank hold MAZE as of Q3 2026.

  • AXQ Capital held 11,991 shares of Maze Therapeutics worth $326K as of Q3 2026.
  • AXQ Capital sold 3,202 Maze Therapeutics shares in Q3 2026, an estimated $88.8K.
  • Maze Therapeutics made up 0.04% of AXQ Capital's portfolio in Q3 2026, its #566 holding.
  • AXQ Capital first reported a position in Maze Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • AXQ Capital's Maze Therapeutics position peaked at $453K in Q2 2026.
  • 95 funds tracked by Wall St. Rank held Maze Therapeutics as of Q3 2026.

Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.